SOPHiA GENETICS (SOPH) Shares Outstanding (Weighted Average) (2020 - 2025)

SOPHiA GENETICS's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) fell 92.78% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (down 92.78% YoY), while the FY2025 annual figure was $4.8 million, down 92.78% from the prior year.
• Shares Outstanding (Weighted Average) came in at $4.8 million for Q4 2025 at SOPHiA GENETICS, up from $4.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $66.7 million in Q4 2024 to a low of $440.0 in Q2 2024.
• A 5-year average of $18.8 million and a median of $4.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) surged 526775.0% in 2021 and slumped 99.99% in 2024, its largest moves.
• SOPHiA GENETICS's Shares Outstanding (Weighted Average) stood at $55.3 million in 2021, then gained by 15.91% to $64.1 million in 2022, then increased by 1.02% to $64.8 million in 2023, then gained by 2.99% to $66.7 million in 2024, then slumped by 92.78% to $4.8 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $4.8 million, $4.2 million, and $590.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison